Epilepsias
Tratamentos Alternativos
DOI:
https://doi.org/10.34024/rnc.1999.v7.8970Palavras-chave:
Epilepsia, drogas antiepilépticas, tratamento alternativo em epilepsiaResumo
Este é um artigo de revisão no qual os autores fazem uma abordagem geral dos principais tratamentos alternativos atualmente utilizados para as epilepsias, dentre eles: acelazolamida, brometos, alopurinol, piracelam, leviracetam, imunoglobulina, dieta cetogénica e corticostertides.
Downloads
Métricas
Referências
Reiss WG & ales KS. Acetazolamide in the treatment of seizures. Ann Pharmacother, 30(5): 514-519, 1996.
Resor SR & Resor LD. Chronic acetazolamide monotherapy in the treatment of myoclonic epilepsy. Neurology, 40(11): 1677-1681, 1990.
Oles KS, Penry JK, Cole DL, Howard G. Use of acetazolamide 20. Shorvon SD. Piracetam. In: Shorvon S, Dreifuss F, Fish Dot as an adjunct to carbamazepine in refractory partial seizures. al. (eds). The Treatment of Epilepsy. Blackwell Science, 1996, Epilepsia, 30(1): 74-78, 1989. p. 466-470.
Oguni H, Hayashi K, Oguni M et al. Treatment of severe 21. Obeso JA. Therapy of myoclonus. Clin Neurosci, 3(4): 253-myoclonic epilepsy in infants with bromide and its borderline 257, 1995-96.variant. Epilepsia, 35(6): 1140-1145, 1994. 22. Ikeda A, Shibasaki H, Tashiro K et al. Clinical trial of piracetam
Meierkord H. Other drugs used in the treatment of epilepsy, in patients with myoclonus: nationwide multiinstitution study In: Shorvon S, Dreifuss F, Fish D et al. (eds). The Treatment in Japan. The Myoclonus/Piracelam study group. Mov Disord, of Epilepsy. Blackwell Science, 1996, p.500-508. 11(6): 691-700, 1996.
James LP, Farrar HC, Griebel ML, Bates SR. Bromism: 23. Bialer M, Johannessen SI, Kupferberg HJ et al. Progress intoxication from a rare anticonvulsant therapy. Pediatr emerg report on new antiepileptic drugs: a summary of the Third care, 13(4): 268-270, 1997. Eilat Conference. Epilepsy Res, 25(3): 299-319, 1996.
Dreifuss F. Fish D, Thomas D, Reynolds E. Others drugs used 24. Kasteleijn-Nolst Trenité DG, Marescaux C, Stodieck S. in treatment of Epilepsy. In: Shorvon S, Dreifuss F. Fish D et Edelbroek PM. Photosensitive epilepsy: a model to study the al. (eds). The treatment of Epilepsy. Blackwell Science, 1996, effects of antiepileptic drugs. Evaluation of the piracetam p. 500-508, analogue, levetiracetam. Epilepsy Res, 25(3): 225-230, 1996.
Steinhoff BJ & Kruse R. Bromide treatment of pharmaco- 25. Van Engelen BGM, Ranier WO, Weemaes CMR et al. Highresistant epilepsies with generalized tonic-clonic seizures: a dose intravenous immunoglobulin treatment in cryptogenic clinical study. Brain Dev, 14(3): 144-149, 1992. West and Lennox-Gastaut Syndrome; an add-on study. Eur J
Dreifuss FE & Bertram EH. Bromide therapy for intractable Pediatr, 153: 762-769, 1994. seizures. Epilepsia, 27(5): 593, 1996. 26. Rijckvorsel-Harmant KV, Delire M, Schmitz-Moorman W,
Woody RC. Bromide therapy for pediatric seizure disorder Wieser HG. Treatment of refractory epilepsy with intravenous intractable to other antiepileptic drugs. J Child Neurol, 5(l): immunoglobulins. Int J Clin Lab Res, 24: 162-166, 1994. 65-67, 1990. 27. Fayad MN, Choueiri R, Mikati M. Landau-Kleffner Syndrome:
Coleman M, Landgrebe M. Landgrebe A. Progressive seizures Consistent Response to Repeated Intravenous y - Doses: A with hyperuricosUria reversed by allopurinol. Arch Neurol, 31: Case Report. Epilepsia, 38(4): 489-494, 1997. 238-242, 1974. 28. Prassad AN, Stafstrom CF, Holmes GL. Alternative Epilepsy
De Marco P & Zagnoni P. Allopurinol and severy epilepsy. Therapies: The Ketogenic Diet, lmmunoglobulins, and Neurology, 36: 1538-1539, 1986. steroids. Epilepsia, 37(suppl 1): S81-S95, 1996.
Mikati M, Erba G, Skouteli H, Gadia C. Pharmacokinetic study 29. Gross-Tsur V. Shalev AS, Kazir E et al. Intravenous highof allopurinol in resistant epilepsy: evidence for significant dose gammaglobulins for intractable childhood epilepsy. Acta drug interactions. Neurology, 40(Suppl. 1): 138, 1990. Neurol, 88: 204-209, 1993.
So EL & Ptaceck L. Failure of allopurinol as an adjunct therapy 30 Swink T Vining EPG, Freeman JM. The Ketogenic Diet: 1997. in intractable epilepsy. Epilepsia, 29(5): 671, 1988. Advances in Pediatrics, 44: 297-329, 1997.
Marrosu F, Marrosu G. Rachele MG et al. Allopurinol add-on 31 Kinsman SL, Vining EPG, Quaskey SA et al. Efficacy of the treatment in intractable seizures. Acta Neurol Napoli, 12(3): Diet for Intractable Seizure Disorders: Review of 58 Cases. 207-213, 1990. Epilepsia, 33(6): 1132-1136, 1992.
Tada H, Morooka K, Arimoto K, Matsuo T. Clinical effects of 32 Hart YM, Cortez M, Andermann F et al. Medical treatment of allopurinol on intractable epilepsy. Epilepsia, 32(2): 279-283, Rasmussen's Syndrome (chronic encephalitis and epilepsy): 1991. Effect of high-dose steroids or immunoglobulins in 19 patients.
Zagnoni PG, Bianchi A, Zolo P et al. Allopurinol as add-on Neurology, 44: 1030-1036, 1994. therapy in refractory epilepsy: a double-blind placebocontrolled randomized study. Epilepsia, 35(1): 107-112, 1994.
Terwinghe G, DaumerieJ, Nicaise CL, Rosillon 0.Therapeutic effect of piracetam In a case of postanoxic action myoclonus. Acta Neurol Belg, 78: 30-36, 1978.
Pranzatelli MR & Nadi NS. Mechanism of action of antiepileptic and antimyoclonic drugs. In: Fahn S, Hallett M, Liiders HO, Marsden CD (eds). Advances in Neurology. Lippincott-Raven, cap. 23, 1995, p.329-357.
Downloads
Publicado
Como Citar
Edição
Seção
Publicado: 1999-04-30
Português
English
Español
